Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06073106 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Study acronym: OPTIMA-C
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 18 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Publications: details revised at 1 of 1 entry
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2023 to Jan 1, 2025
    • Site details revised
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
5,418 trials monitored
See 296 trials at risk
3,531 trials monitored
See 153 trials at risk
The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty. In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.
Trial Details
NCT Number NCT06073106
Lead Sponsor Tan Tock Seng Hospital
Collaborators: Rehabilitation Research Institute of Singapore (RRIS), Woodlands Health (WH)
Conditions
(from sponsor)
Stroke, Traumatic Brain Injury, Knee Osteoarthritis, Breast Cancer
Related terms Brain Injuries, Traumatic, Breast Neoplasms, Frailty, Osteoarthritis, Knee, Stroke
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov